These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31987970)

  • 1. The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo.
    Paillas S; Then CK; Kilgas S; Ruan JL; Thompson J; Elliott A; Smart S; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):212-221. PubMed ID: 31987970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization
    Groselj B; Ruan JL; Scott H; Gorrill J; Nicholson J; Kelly J; Anbalagan S; Thompson J; Stratford MRL; Jevons SJ; Hammond EM; Scudamore CL; Kerr M; Kiltie AE
    Mol Cancer Ther; 2018 Feb; 17(2):381-392. PubMed ID: 28839000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romidepsin: a novel histone deacetylase inhibitor for cancer.
    Bertino EM; Otterson GA
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1151-8. PubMed ID: 21699444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
    Li H; Ma L; Bian X; Lv Y; Lin W
    Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
    Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
    Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice.
    Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC
    Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC inhibitors: a new radiosensitizer for non-small-cell lung cancer.
    Zhu L; Wu K; Ma S; Zhang S
    Tumori; 2015; 101(3):257-62. PubMed ID: 25953446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.
    Safari M; Litman T; Robey RW; Aguilera A; Chakraborty AR; Reinhold WC; Basseville A; Petrukhin L; Scotto L; O'Connor OA; Pommier Y; Fojo AT; Bates SE
    Mol Cancer Res; 2021 Aug; 19(8):1361-1374. PubMed ID: 34050002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
    Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination.
    Koprinarova M; Botev P; Russev G
    DNA Repair (Amst); 2011 Sep; 10(9):970-7. PubMed ID: 21824827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.
    Leiker AJ; DeGraff W; Choudhuri R; Sowers AL; Thetford A; Cook JA; Van Waes C; Mitchell JB
    Clin Cancer Res; 2015 Jun; 21(12):2792-801. PubMed ID: 25724523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
    Groselj B; Kerr M; Kiltie AE
    Radiother Oncol; 2013 Sep; 108(3):429-33. PubMed ID: 23932191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.
    Hoffmann MJ; Meneceur S; Hommel K; Schulz WA; Niegisch G
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33670166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.
    Zhang Y; Adachi M; Zou H; Hareyama M; Imai K; Shinomura Y
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):859-66. PubMed ID: 16751067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies.
    Jain N; Odenike O
    Expert Opin Pharmacother; 2010 Dec; 11(18):3073-84. PubMed ID: 21080855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
    Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of class I histone deacetylase inhibitor romidepsin in combination regimens.
    Petrich A; Nabhan C
    Leuk Lymphoma; 2016 Aug; 57(8):1755-65. PubMed ID: 27118119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
    Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
    Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy.
    Pojani E; Barlocco D
    Curr Med Chem; 2021; 28(7):1290-1303. PubMed ID: 32013816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.